Update your tester profile Login
  • *NEW INFO* Change in Prism's Entrance for Screenings

    University Enterprise Laboratories is currently undergoing construction on the south side of the building. 

    The south entrance will be closed starting Wednesday, July 18th2018 until further notice. 

    FOR SCREENINGS: Please enter through the East entrance (closest side to Hwy 280). In order to get inside, please pick up the phone in the weather proof box. This will ring to the nurses station and a staff member will be able to let you in. 

    Please tell them you are here for a screening appointment (if you know the study number even better!). 

    If you pick up the phone and it doesn't have a dial tone, remain on the line until someone answers (it will still ring in the nurses station). 

    If no one answers the phone please knock twice and then try calling again.

     

    Thank you for your patience during the construction. 

    Prism Staff 

  • Register with Our Database

    Get started on the volunteer process by registering your basic information with our database. This information is provided to help us determine your eligibility for current and future studies.

    If you have registered with Prism in the past, please call Dayna 651-724-5047 to update your profile or learn about available studies. 


    Thanks for your interest, you'll find the intake form here. 

     Unfortunately at this time, Prism can not allow volunteers who live over 200 miles away to participate in research studies. If you live out of state or over 200 miles away please call Geoff at 651-641-2911 with questions. 

    We will not share or sell this info with any third party.

  • Connect With Prism Research on Social Media

    You can WIN TICKETS VIA Prism's Facebook page!

    Have you LIKED Prism Clinical Research on Facebook?

    Have you TAGGED Prism Clinical Research on Twitter?

    Have you FOLLOWED Prism Clinical Research on Instagram?

     

    Use the link below:↓

    https://www.facebook.com/PrismResearch/

  • Refer Your Friends & Family to Participate

    Simply help us get the word out about Prism Clinical Research and we’ll give you $100 for every friend you refer that completes a study.

    It’s that easy! Make money with each referral, and there’s no limit to how many friends you can refer!

    Rules:

    • Subject must qualify for a study.
    • Subject may not be referred more than one time.
    • Subjects eligible for Referral: (1) Must not be in Prism Clinical Research database; (2) Must not have participated in any prior study at Prism.
    • In the event that a subject is referred by multiple people, the first person who referred will receive payment.
    • Eligibility will be determined by Prism. Prism reserves the right to revise or eliminate this program at any time without notice.

     

     

  • Let's Talk About Endometriosis

    Prism Research has upcoming studies for individuals diagnosed with moderate to severe Endometriosis.  These studies will help determine how an investigational drug is broken down and removed from the body.

     If you or someone you know has been diagnosed with endometriosis and are interested in being considered for these studies, please contact Dayna at 651-724-5047 or register with our database and we will call you. Financial compensation for study participation ranges from $225-$2600.

    Let's Talk 

    Please contact Dayna at 651-724-5047 or daynas@prismresearchinc.com

     

     

  • Diagnosed with Celiac Disease?

    Prism Research has upcoming studies for individuals who have been diagnosed with Celiac Disease.  These FDA approved studies will help determine how an investigational drug being developed for Celiac Disease is broken down and removed from the body in volunteers diagnosed with Celiac Disease.

    If you or someone you know has been diagnosed with Celiac Disease and are interested in being considered for these studies, please contact Dayna at 651-724-5047 or register with our database and we will call you. Participants who qualify will receive a no cost health evaluation in addition to financial compensation for study participation time.

    Please contact Dayna at 651-724-5047 or daynas@prismresearchinc.com for more information on these upcoming studies for individuals diagnosed with Celiac Disease. 

    Study 1803 Part B

    Cour Pharmeceuticals New Drug

    Recruiter: 651-724-5047

     

  • Diagnosed with Liver Impairment?

    Prism Research has upcoming studies for individuals diagnosed with liver impairment.  These studies will help determine how an investigational drug is broken down and removed from the body in volunteers with various degrees of liver impairment when compared to volunteers with normal liver function.

     If you or someone you know has been diagnosed with liver impairment and are interested in being considered for these studies, please contact Dayna at 651-724-5047 or register with our database and we will call you. Financial compensation for study participation ranges from $400-$3500.

    Please contact Dayna at 651-724-5047 or daynas@prismresearchinc.com

    Current Studies: 1810, 1813 & 1817

  • Diagnosed with Kidney Impairment?

    Prism Research has upcoming studies for individuals diagnosed with kidney impairment.  These studies will help determine how an investigational drug is broken down and removed from the body in volunteers with various degrees of kidney impairment when compared to volunteers with normal kidney function.

     If you or someone you know has been diagnosed with kidney impairment and are interested in being considered for these studies, please contact Lindsay at 651-368-3360 or register with our database and we will call you. Financial compensation for study participation ranges from $400-$3500.

    Please contact Lindsay at 651-368-3360 or lindsayd@prismresearchinc.com

  • Celiac Disease: 1803 Part B

    Celiac Disease Study

    CLINICAL RESEARCH STUDY: 1803 Part B

    PRISM CLINICAL RESEARCH

    Purpose:

    • To evaluate an investigational drug being developed for the treatment of Celiac Disease.

     

    GENERAL STUDY REQUIREMENTS:

    • Men and Women who are willing to use an acceptable form of birth control, between the ages of 18 to 75 with a BMI between 18.0 -25.0 kg/m2.
    • Diagnosed by biopsy with Celiac Disease
    • No known gluten exposure for at least 10 days prior to screening visit

     

    STUDY DURATION:

    • In Clinic Stay: 2 Clinical stays of 3 nights/4 days.
    • Clinic Visits: approximately 5 to 6 including screening.
    • Phone Calls: approximately 9-10 phone follow ups.
    • Total study duration is approximately 7 months.

     

    METHOD OF ADMINISTRATION:

    Intravenous Administration

     

    STUDY COMPENSATION:

      • Compensation for Study Participation Time Up To: $2,825.00

     

    RECRUITMENT CONTACT:

    Dayna 651-724-5047 or daynas@prismresearchinc.com

     

  • Asthma: Clinical Research Study 1804

    PURPOSE:

    * To evaluate the safety and tolerability of an investigational drug in individuals diagnosed with persistent asthma who are being treated and are on a stable asthma therapy.

     

    GENERAL STUDY REQUIREMENTS:

    *Men and Women Between The age of 18 and 65

    * Individuals with Asthma on a stable Asthma Therapy

     

    STUDY DURATION:

    * 3 In-Clinic Stays: Each Lasting 4 nights/5 days

    * Return Clinic Visits: 10, Including Screening

    * Total Study Duration is Approximately 35 Weeks

     

    METHOD OF ADMINISTRATION:

    * Subcutaneous Dosing

     

    STUDY COMPENSATION:

    * Compensation for Study Participation may be granted for time and travel

     

    RECRUITMENTCONTACT:

    *  Dayna 651-724-5047 or daynas@prismresearchinc.com

  • Dialysis: Clinical Research Study 1809

    Study for Hemodialysis Patients

    Clinical RESEARCH study: 1809 (DS2330-A-U103)

     

    PRISM clinical RESEARCH

     

    Purpose:

    •  To evaluate the safety and tolerability of an investigational drug in individuals on hemodialysis and in combination with a known FDA approved medication, sevelamer.

     

    GENERAL STUDY REQUIREMENTS:

    •  Men and Women between the age of 18 and 80 with a body mass index (BMI) between 18kg/m²and 40kg/m².
    •  Volunteers must be on hemodialysis for the past 3 months

     

    STUDY DURATION:

    •  In Clinic Stay: 15 nights/16 days.
    •  Return Clinic Visits:  Up to 8, including screening.
    •  Total study duration is approximately 10.5 weeks (including a 29 day screening period).

     

    METHOD OF ADMINISTRATION:

     Oral Administration

     

    STUDY COMPENSATION:

    •  Compensation for Study Participation Time Up To: $5,195.00

     

    RECRUITMENT CONTACT:

     

     

     

     

  • Liver Impairment: Clinical Research Study 1810

     

     Hepatic Study

    CLINICAL RESEARCH STUDY: 1810

    PRISM CLINICAL RESEARCH

     

     

    PURPOSE:

    •  To evaluate the absorption/elimination rate and safety/tolerability of an investigational drug being developed for the treatment of type 2 diabetes mellitus.

     

    GENERAL STUDY REQUIREMENTS:

    •  Men and Women Between the ages of 18 and 75 years old
    •  Hepatic volunteers: must be diagnosed with moderate liver disease.
    •  Healthy volunteers: must be healthy; not being evaluated or treated for any medical conditions.

     

    STUDY DURATION:

    •  1 In-Clinic Stay: Lasting 4 nights/ 5 days
    •  1 Follow Up Phone Call
    •  Total Study Duration is Approximately 2 Months

     

    METHOD OF ADMINISTRATION:

    •  Oral Administration

     

    STUDY COMPENSATION:

    •  Compensation for Study Participation may be granted for time and travel up to $1295.00

     

    RECRUITMENT CONTACT:

     

     

     

     

  • Kidney Impairment: Clinical Research Study 1812

    Renal Impairment Study

    Clinical RESEARCH study: 1812

     

    PRISM Clinical RESEARCH

     

     

     

     

    Purpose:

    •  A research study to evaluate the safety and tolerability of an investigational drug in individuals with renal impairment compared with individuals without renal impairment.

     

    GENERAL STUDY REQUIREMENTS:

    •  Men and Women Who are not able to become pregnant, between the ages of 18 to 75 with a BMI between 17.5 and 36 kg/m2.
    •  Medical conditions and medications must be stable in the opinion of the study doctor.

     

    STUDY DURATION:

    •  In Clinic Stay: 6 nights/7 days.
    •  Clinic Visits: up to 3 including screening and possible Follow-up visit.
    •  Total study duration is approximately 6 weeks (including a 14-day screening period).

     

    METHOD OF ADMINISTRATION:

    •  Oral Administration

     

    STUDY COMPENSATION:

    •  Compensation for Study Participation Time Up To: $2,385.00

     

    RECRUITMENT CONTACT:

     

     

  • Liver Impairment: Clinical Research Study 1813

    Abnormal Liver Function Study

    CLINICAL RESEARCH STUDY: 1813

    PRISM CLINICAL RESEARCH

    PURPOSE:

    To determine how the investigational drug is absorbed, broken down, and removed from the body in volunteers with abnormal liver function compared to volunteers with normal liver function.

     

    GENERAL STUDY REQUIREMENTS:

    • Men and Women Between the ages of 18 and 70 years old.
    • Abnormal liver function volunteers: must have mild/moderate abnormal liver function due to diagnosed liver disease.
    • Healthy volunteers: must be healthy; not being evaluated or treated for any medical conditions.

     

    STUDY DURATION:

    • 1 In-Clinic Stay: Lasting 4 nights/ 5 days
    • Up to 2 clinic visits for Screening
    • 1 Follow Up Phone Call or clinic visit
    • Total Study Duration is Approximately 64 days, including screening

     

    METHOD OF ADMINISTRATION:

    • Oral Administration

     

    STUDY COMPENSATION:

    • Compensation for Study Participation may be provided for time and travel up to $1785.00

     

    RECRUITMENT CONTACT:

     

     

     

     

     

  • Kidney Impairment: Clinical Research Study 1816

     #18300142.0
     

    Renal Impairment Study

    Clinical RESEARCH study: 1816

     

    PRISM CLINICAL RESEARCH

      

    Purpose:

    •  To evaluate the safety and tolerability of an investigational drug in individuals with renal impairment.

     

    GENERAL STUDY REQUIREMENTS:

    • Men and Women, between the ages of 30 and 80
    • Medical conditions and medications must be stable in the opinion of the study doctor.
    • Volunteers must agree to use contraception, if applicable

     

    STUDY DURATION:

    • In Clinic Stay: 4 in clinic stays of 48 hours each.
    • Clinic Visits: 7, including screening.
    • Telephone Visit: 1.
    • Total study duration is approximately 14 weeks (including a 28-day screening period).

     

    METHOD OF ADMINISTRATION:

    • Oral administration

     

    STUDY COMPENSATION:

    •  Compensation for Study Participation Time Up To: $3525.00

     

    RECRUITMENT CONTACT:

  • Liver Impairment: Clinical Research Study 1817

    LIVER IMPAIRMENT STUDY

    CLINICAL RESEARCH STUDY: 1817

    PRISM CLINICAL RESEARCH

    PURPOSE:

    • To determine how the investigational drug is absorbed, broken down, and removed from the body in volunteers with abnormal liver function compared to volunteers with normal liver function.

     

    GENERAL STUDY REQUIREMENTS:

    • Men and women between the ages of 18 and 80 years old.
    • Liver Impairment volunteers: must have mild/moderate/severe liver impairment due to diagnosed liver disease.
    • Healthy volunteers: must be healthy; not being evaluated or treated for any medical conditions.

     

    STUDY DURATION:

    • 1 In-Clinic Stay: Lasting 8 nights/ 9 days
    • Clinic Visits: 1(screening)
    • Total Study Duration is Approximately 39 days, including screening

     

    METHOD OF ADMINISTRATION:

    • Oral Administration

     

    STUDY COMPENSATION:

    • Compensation for Study Participation may be provided for time and travel up to $2620.00

     

    RECRUITMENT CONTACT:

  • Upcoming Studies

     

     

     Prism has a variety of upcoming studies to participate in: 

    • Studies for healthy males and females 
    • Liver Impairment 
    • Kidney Impairment 
    • Diabetes

    To be put on the call list and receive more information, when available, please contact Dayna at daynas@prismresearchinc.com or Lindsay at lindsayd@prismresearchinc.com.

Referral Guidelines

Simply help us get the word out about Prism Clinical Research and we’ll give you $100 for every friend you refer that completes a study.

It’s that easy! Make money with each referral, and there’s no limit to how many friends you can refer!

Rules:

  • Subject must complete the study.
  • Subject may not be referred more than one time.
  • Subjects may not refer each other.
  • Subject must complete the study before payment can be received.
  • Subjects eligible for Referral: (1) Must not be in Prism Clinical Research database; (2) Must not have participated in any study at Prism.
  • In the event that a subject is referred by multiple people, the first person who referred will receive payment.
  • Eligibility will be determined by Prism. Prism reserves the right to revise or eliminate this program at any time without notice.

Please provide us with your contact information (below) and will get back to you as soon as possible.

If you have a general question, check Volunteer FAQ for an answer. If you're unsure of who to contact, please visit the Contact Us page.

Cancel